These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 109454)

  • 1. Relationship between alpha and beta cell function before and after metabolic control in ketotic diabetic subjects.
    Larkins RG; Martin FI; Alford FP; Chisholm DJ
    J Clin Endocrinol Metab; 1978 Jan; 46(1):131-9. PubMed ID: 109454
    [No Abstract]   [Full Text] [Related]  

  • 2. The alpha cell in diabetic ketoacidosis.
    Bartle B
    JAMA; 1973 Sep; 225(12):1533. PubMed ID: 4199183
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
    Linfoot P; Bergstrom C; Ipp E
    Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis: counter-regulatory hormones versus insulin in therapeutic response. Report of a case.
    Schade DS; Kaufman E; Eaton RP
    Rocky Mt Med J; 1977; 74(6):312-5. PubMed ID: 416484
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
    Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
    Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP
    J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new beta cell efficiency test in the islands of Langerhans].
    Páv J; Srámková J
    Vnitr Lek; 1977 Jun; 23(7):639-46. PubMed ID: 331663
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of somatostatin on established induced ketosis.
    Fallucca F; Barbetti F; Maldonato A; Spallone V; Giangrande L; Gambardella S
    Horm Metab Res; 1982 Oct; 14(10):512-5. PubMed ID: 6129185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients.
    Foucar E; Field JB
    J Clin Endocrinol Metab; 1972 Aug; 35(2):288-98. PubMed ID: 4627325
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose intolerance in cystic fibrosis.
    Handwerger S; Roth J; Gorden P; Di Sant' Agnese P; Carpenter DF; Peter G
    N Engl J Med; 1969 Aug; 281(9):451-61. PubMed ID: 4894429
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous alanine on blood glucose, glucagon and growth hormone levels in diabetic children.
    Soltész G; Molnár D; Mestyán J
    Acta Paediatr Acad Sci Hung; 1982; 23(2):195-200. PubMed ID: 6814169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment].
    Assan R; Hautecouverture G; Guillemant S; Dauchy F; Protin P; Derot M
    Pathol Biol (Paris); 1969 Dec; 17(23):1095-105. PubMed ID: 4985195
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of glucagon in diabetes.
    Unger RH; Orci L
    Arch Intern Med; 1977 Apr; 137(4):482-91. PubMed ID: 403869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
    Adamson U; Cerasi E
    Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children.
    Lightner ES; Kappy MS; Revsin B
    Pediatrics; 1977 Nov; 60(5):681-8. PubMed ID: 411105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various disturbances in beta cell function in diabetes mellitus].
    Lohmann D; Verlohren HJ; Ellorhaoui M
    Endokrinologie; 1977 Jul; 69(2):239-45. PubMed ID: 334525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.